Didesmethyl cariprazine 是 Cariprazine 的代谢物，作为主要的循环活性部分。Didesmethyl cariprazine 的半衰期较长，为 1-3 周。Cariprazine是一种新型抗精神病候选药物，能结合 D3, D2 和 5-HT1A 。
Didesmethyl cariprazine is a metabolite of Cariprazine and acts as the predominant circulating active moiety. Didesmethyl cariprazine has a long half-life of 1-3 weeks. Cariprazine is a antipsychotic drug candidate that exhibits high affinity for the D3 and D2 receptors, and moderate affinity for the 5-HT1A receptor[1].
[1]. Citrome L, et al. Cariprazine for acute and maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy. Neuropsychiatr Dis Treat. 2018 Oct 5;14:2563-2577.
动态评分
0.0